The Medicine Maker 2019 Innovation Awards included Schott’s Everic glass vials as a deserved runner up. Biopharmaceuticals are filling company pipelines and many of these drug products are highly sensitive, which means that special consideration must be paid to the primary packaging. Not all glass is created equal and using the right glass and can make a huge difference in terms of reducing unwanted effects between the drug and the packaging, and reducing line downtime through reduced breakage.
Stephanie Sutton | | Interview
Why does glass matter in the pharma industry?
Borosilicate glass is considered the gold standard in the pharmaceutical packaging industry. It is chemically resistant and, like glass in general, remarkably strong. It was first developed by Otto Schott in 1911, who also founded our company.
Traditional fill and finish operations for drugs rely on bulk filling processes, which allow for high throughput in a short period of time. However, glass-to-glass contact and the mechanical stress on the containers can create small glass particles that can contaminate the medication. In addition, containers may be damaged or even broken. When highly valuable drugs, such as biopharmaceuticals, are involved breakage is particularly problematic but, whatever the drug, it results in downtime, maintenance, and overall manufacturing costs. The glass you use matters. Some types of glass are more prone to breakage than others, and some glass is also more prone to interacting with drugs. For example, glass with high alkalinity levels, high pH-shifts, and high conductivity can increase the risk of drug instability.
Read the full article now
Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE!
Or register now - it’s free!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Medicine Maker magazine